|Bid||9.06 x 800|
|Ask||9.06 x 900|
|Day's range||9.00 - 9.36|
|52-week range||4.37 - 37.06|
|Beta (5Y monthly)||1.59|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
SEATTLE, March 08, 2023--NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq Stock Market Rules, equity inducement awards to 16 new employees.
SEATTLE, March 01, 2023--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to participate in a panel discussion, "AI-Driven Disruptions To Genomics & Computational Drug Discovery", from the 43rd Annual Cowen Health Care Conference. The conference will be held March 6-8, 2023.
SEATTLE, February 28, 2023--NanoString reports Q4 and FY22 operating results.